Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells

Document Details

Document Type
Pub Defense Publication
Publication Date
Jul 01, 2018
Source ID
10.1016/j.canlet.2018.03.037

Entities

People

  • Alexander J.r. Bishop
  • Alfeu Zanotto-Filho
  • Aparna Gorthi
  • Eva Loranc
  • John Kuhn
  • July Carolina Romero
  • Raymond Benavides
  • Robert L. Reddick
  • Rosangela Mayer Gonçalves
  • Sonal Tonapi
  • Subapriya Rajamanickam
  • V. Pragathi Masamsetti
  • Yidong Chen

Organizations

  • Cancer Prevention and Research Institute of Texas
  • Congressionally Directed Medical Research Programs
  • Max and Minnie Tomerlin Voelcker Fund
  • Ministry of Science, Technology and Innovation
  • National Cancer Institute
  • National Institutes of Health
  • San Antonio Area Foundation